Clinical Trial

Pulmonary Artery Catheter in Cardiogenic Shock Trial

Study acronym: PACCS
Recruiting
View on ClinicalTrials.gov →
Summary
The primary objective of the PACCS trial is to assess if early invasive hemodynamic assessment and ongoing management with a PAC in patients with cardiogenic shock due to acutely decompensated heart failure (AHDF-CS) is associated with lower in-hospital mortality risk compared to the current standard of care with no or delayed PAC assessment.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2022-08-01; most recent amendment 2025-10-27.
Status change: Enrolling by Invitation → Recruiting 2024-02-20
Status change: Not Yet Recruiting → Enrolling by Invitation 2022-09-06
Trial Details
NCT Number NCT05485376
Lead Sponsor Tufts Medical Center
Conditions Cardiogenic Shock, Heart Failure
Enrollment 400 participants
Start Date 2022-08-23
Primary Completion 2026-09-01 (estimated)
Study Completion 2026-09-01 (estimated)
Updated on ClinicalTrials.gov 2025-10-29